Experience

Cooley Advises DFJ on Growth Investment in Paradigm Health

April 23, 2025

Cooley advised DFJ Growth on its growth investment in Paradigm Health, a company on a mission to bring equitable access to clinical trials. This investment will bolster Paradigm’s innovative efforts and accelerate its growth trajectory. DFJ Growth is a venture capital firm that focuses on investing in innovative, high-growth companies. Lawyer Sale Kwon led the Cooley team advising DFJ Growth.

Related contacts

Sale Kwon
Partner, Palo Alto
Alanna Anderson
Associate, Palo Alto
Caroline Vu
Special Counsel, Palo Alto

Related Practices & Industries

Cooley Represents Wheeler Bio in $35M Series A-1 Financing Round

March 20, 2025

Cooley represented Wheeler Bio in the closing of its $35 million Series A-1 financing round. This funding will support Wheeler Bio’s ongoing efforts to expand its capabilities and accelerate the advancement of its partners’ therapies. Lawyers Sale Kwon and Emily Lee led the Cooley team advising Wheeler Bio, a developer of biomanufacturing services designed to translate therapeutic innovations into clinical impact.

Related contacts

Sale Kwon
Partner, Palo Alto
Emily Lee
Associate, Palo Alto
Celine Koh
Associate, Palo Alto

Related Practices & Industries

Cooley Advises RegCell on Transition to Being US-Based Company While Securing up to $45.8M of Funding

March 18, 2025

Cooley represented Japanese-founded RegCell in its transition to being a US-based company in connection with the closing of $45.8 million of funding, consisting of $8.5 million in seed financing – co-led by The University of Tokyo Edge Capital Partners and Fast Track Initiative – and up to $37.3 million in nondilutive funding from Japan’s Agency for Medical Research and Development. Lawyers Dave Peinsipp, Sale Kwon and Yichen Liu led the Cooley team advising RegCell, a developer of cell therapies intended to treat autoimmune diseases and cancer.

Related contacts

David Peinsipp
Partner, San Francisco
Sale Kwon
Partner, Palo Alto
Yichen Liu
Associate, Palo Alto

Related Practices & Industries

Auditoria.AI Closes $38 Million Series B Financing

February 24, 2025

Cooley represented Auditoria.AI in its $38 million Series B financing led by Innovius Capital, with participation from Dell Technologies Capital, Sentinel Global and existing investors including Venrock, Neotribe Ventures, Engineering Capital and KPMG Ventures. Partner Sale Kwon led the Cooley team advising Auditoria.AI, an artificial intelligence-driven software as a service automation provider for corporate finance that automates finance processes in vendor management, accounts payable and receivable, and accruals to accelerate cash performance.

Related contacts

Sale Kwon
Partner, Palo Alto
Rachel Lydon
Associate, San Diego
Jovian Marcelo
Associate, Palo Alto
Joseph J. Kim
Associate, Palo Alto

Related Practices & Industries

Cooley Represents ANAFLASH in Acquiring Legato Logic

February 5, 2025

Cooley represented ANAFLASH in its strategic acquisition of Legato Logic, accelerating the company’s development of non-volatile compute-in-memory tech and driving progress toward battery-powered intelligent sensors. Specializing in non-volatile edge artificial intelligence (AI) processor technology, ANAFLASH develops processors with non-volatile memory integrating low-power AI acceleration engines. Lawyers Sale Kwon and Jeff Beuche led the Cooley team representing ANAFLASH.

Related contacts

Sale Kwon
Partner, Palo Alto
Jeffrey A. Beuche
Partner, Colorado
Alanna Anderson
Associate, Palo Alto
Roger Cain
Associate, Palo Alto

Related Practices & Industries

View more

Admissions and credentials

California

Rankings and accolades

The Legal 500 US: Next Generation Partner for Venture Capital and Emerging Companies (2021 – 2024)

Memberships and affiliations

American Bar Association (ABA)